News - MiGenTra

Press Releases

Oct 04, 2023

SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries

download PDF

Mar 06, 2023

Participants Dosed on Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa

download PDF

Nov 29, 2022

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

download PDF

Nov 03, 2022

MiGenTra Highlights How Biosimilars Are Transforming Healthcare in Africa at the Festival of Biologics

download PDF

May 18, 2022

MiGenTra Marks One-Year Anniversary by Attending Africa Health ExCon 2022

download PDF

Mar 07, 2022

Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe

download PDF

Mar 02, 2022

Product Development Company MiGenTra Announces Formation of International Advisory Board

download PDF

May 27, 2021

ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH – A Healthcare Transforming Medicines Company

download PDF

Media & Downloads

MiGenTra White Paper: How Biosimilars are Transforming Healthcare

White Paper: How Biosimilars are Transforming Healthcare

download PDF

Corporate Presentation

Company Slide Deck

download PDF

Press Contact

Sarah Wandrey, Corporate Communications

Sarah Wandrey
Corporate Communications
Phone: +49 (0) 30 3229 35 144
Email: press@probiogen.de